Group items tagged

Market Overview: Next-generation antibody therapeutics includes the use of new improvised therapeutic antibody to form innovative medicines for treating various diseases. Next-generation antibody therapeutics is developed clinically by pharmaceutical and biotechnology companies for several diseases. The Next Generation Antibody Therapeutics Market size was worth $ XX million in 2018 and is forecasted to reach $ XX million by 2026, expected to grow at a high CAGR during the forecast period 2019-2026. Market Dynamics: The Next Generation Antibody Therapeutics Market is growing due to several factors such as rising incidence of chronic diseases, increasing emergence of antibody technology, new drug discovery, large number of government initiatives, and growing research and development activities for new therapies. Rising prevalence of chronic disease such as cancer, asthma, diabetes and COPD are boosting the growth of the next generation antibody therapeutics market. For instance, according to National Cancer Institute in 2018, in United States, an estimated 1,735,350 new cases of cancer will be diagnosed and 609,640 people will die from the disease. The development of next-generation monoclonal antibodies has expanded beyond oncology into all therapeutic areas. For instance, ADCs were initially focused primarily on cancer, but Genentech has applied to infectious diseases, leading to the discovery and development of THIOMAB antibiotic conjugates (TACs) for the treatment of methicillin-resistant Staphylococcus aureus (MRSA). The technological advancements in antibody therapeutics have led to the development of more efficient antibody therapeutics, hence, driving the growth in the next-generation antibody therapeutics market. However, stringent government regulation, high cost and time required for research and development activities are some of the factors hindering the growth for global next-generation antibody therapeutics market. Market Segmentation: Based o

A humble start by M. K. Narasinga Rao and Chitra krishnan into health care sector, Magal health care was formed in 2009, dealing products with international quality compliance ensuring not only complete credibility of the products but also credible services to the customers and in turn their customers. Based on extensive long term experience of distribution and experience in sales and marketing of medical devices & medical consumables within the sub-continent region, and with a comprehensive understanding of the challenges facing International Principles, We provide them with single channel of communication & single point of management . We take all the necessary steps in order to provide our patients with Access to the state of the art Medical technologies and Medical devices of the highest standard whilst still delivering Value for Money. With an ability to be sensitive towards market dynamism, Magal is evolving continuously, offering a better and wider spectrum of products that are innovative, affordable and at the forefront of medical technology to its valued clients. We carry out our business with the highest level of ethics and morality, adopting a strict code of conduct in keeping with those of the medical profession. The Future Magal Healthcare envisages adding more no of healthcare products to its current list that will enable it to provide more comprehensive solutions to meet the ever growing product and process demands of customers. Customer base The great amount of trust and faith reposed by customers in Magal Healthcare's capabilities is evident from its long list of customers, who always turn to Magal Healthcare to fulfill their ever growing requirements. Magal Healthcare Pvt. Ltd. to be identified by the industry as one stop shop for all healthcare related equipment distributor and equipped with sufficient, proper people for sales, service and administration. Visit:http://magal.in

[311 Pages Report] Healthcare IT Market report categorizes Healthcare Information Technology Market by Delivery Mode (On-Premises, Web-Based Services & Cloud Computing), Components, by Application [Provider IT (EMR, PACS, CPOE, RIS, CDSS, RCM, Claims Management, Payroll), Payer IT (CRM, Fraud Detection)] & by Geography

Healthcare IT Market report categorizes Healthcare Information Technology Market by Delivery Mode (On-Premises, Web-Based Services & Cloud Computing), Components, by Application [Provider IT (EMR, PACS, CPOE, RIS, CDSS, RCM, Claims Management, Payroll), Payer IT (CRM, Fraud Detection)] & by Geography

The report extensively covers the healthcare provider IT and payer IT markets. The market in this report has been segmented on the basis of its applications, delivery modes, and components. Based on applications, the healthcare information technology is segmented into provider (clinical information technology and non-clinical information technology) and payer, while the market by delivery mode is further categorized as on-premises, web-based, and cloud-based.

The "Healthcare IT Market By Application [Provider IT (EMR, PACS, CPOE, RIS, CDSS, RCM, Claims Management, Payroll), Payer IT (CRM, Fraud Detection)], Delivery Mode (On-Premises, Web-Based Services & Cloud Computing) & Component -Global Forecasts to 2017" analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, APAC, and Rest of the World.

Understanding the healthcare industry structure can help in gaining an insight into the changing needs of its affiliated IT market. The healthcare industry consists of three major participants - the providers, the payors, and the consumers. As the overall industry is moving towards integration, an insight into each participant's needs could help system providers design overarching systems that simultaneously cater to all the unmet requirements.

Healthcare IT Market By Application [Provider IT (EMR, PACS, CPOE, RIS, CDSS, RCM, Claims Management, Payroll), Payer IT (CRM, Fraud Detection)], Delivery Mode (On-Premises, Web-Based Services & Cloud Computing) & Component - Global Forecasts to 2017

North American Healthcare IT Market, By Application [Provider IT (EMR, PACS, CPOE, CDSS, RCM, Claims Management, Payroll), Payer IT (CRM, Fraud Detection)], Delivery Mode (On-Premises, Web-Based Services & Cloud Computing) & Component -Forecasts to 2017

Healthcare IT Market By Application [Provider IT (EMR, PACS, CPOE, RIS, CDSS, RCM, Claims Management, Payroll), Payer IT (CRM, Fraud Detection)], Delivery Mode (On-Premises, Web-Based Services & Cloud Computing) & Component - Global Forecasts to 2017

The North America home healthcare market was valued at $90.9 billion in 2012; it is poised to grow at a CAGR of 7.5% to reach $130.4 billion by 2017.

Healthcare IT Market By Application [Provider IT (EMR, PACS, CPOE, RIS, CDSS, RCM, Claims Management, Payroll), Payer IT (CRM, Fraud Detection)], Delivery Mode (On-Premises, Web-Based Services & Cloud Computing) & Component - Global Forecasts to 2017